Navigation Links
Researcher IDs Narcolepsy as Autoimmune Disease
Date:5/4/2009

Discovery of 2 gene variants that kill off protective hormone could lead to new treatments

MONDAY, May 4 (HealthDay News) -- Stanford University researchers say they have determined that the sleep disorder narcolepsy is actually an autoimmune disease.

The finding, published in the May 3 online issue of Nature Genetics, links narcolepsy to mutations of two genes involved in critical roles in protecting the body from disease. These two variations, they say, are likely conspirators against hypocretin, a hormone that promotes wakefulness, and that narcoleptics have been found to lack.

Narcolepsy causes excessive drowsiness, to the point of the person having brief but sudden bursts of sleep during the day. The condition, which affects about one in 2,000 people, also causes poor nighttime sleep patterns and even cataplexy -- a sudden loss of muscle tone and strength.

"This is a very important finding," sleep disorder expert Merrill Mitler, program director at the U.S. National Institute of Neurological Disorders and Stroke, said in a Stanford news release. "It puts in place another piece of the puzzle and shows a way to link [this gene variant] to hypocretin-containing neurons via an autoimmune attack."

The researchers conducted genetic studies on 1,800 people with a variant for the human leukocyte antigen, or HLA, gene, which helps the immune system identify foreign bodies it needs to eliminate to protect the body. Previous studies had linked the HLA variant to narcolepsy, a condition nearly half the study subjects had.

The Stanford team found that all the study participants with narcolepsy also had a mutated gene link to T-cells, which are vital cogs in all the body's immune responses.

Dr. Emmanuel Mignot, director of Stanford's Center for Narcolepsy, said it's likely that HLA and the T-cell variant interact in a way that kills hypocretin cells, although his team's findings did not determine that direct relationship.

"For a long time, people have suspected narcolepsy had something to do with the immune system -- that it was killing cells that produce hypocretin," Mignot, a professor of psychiatry and behavioral science, said in the news release. "But there hasn't been direct proof. Our discovery clearly shows narcolepsy is an autoimmune disease."

If further study can reveal the two mutations work together, scientists may be able to later identify people predisposed to narcolepsy and find ways to prevent its development, he said. It may also lead to discoveries concerning other more common autoimmune afflictions such as multiple sclerosis and juvenile diabetes.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about narcolepsy.



-- Kevin McKeever



SOURCE: Stanford University School of Medicine, news release, May 3, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. Bipolar disorder relapses halved by Melbourne researchers
6. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
7. High and mighty: first common height gene identified by researchers behind obesity gene finding
8. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
9. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
10. Researchers develop long-lasting growth hormone
11. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researcher IDs Narcolepsy as Autoimmune Disease
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: